1. Transcatheter mitral valve therapy: The event horizon
Vinay Badhwar, MD, Vinod H. Thourani, MD, Gorav Ailawadi, MD, Michael Mack, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 152, Issue 2, Pages (August 2016)
DOI: /j.jtcvs
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Examples of current TMVR devices under active clinical investigation. A, The Tendyne (Abbott Vascular, Santa Clara, Calif). B, The CardiaQ Valve (Edwards Lifesciences, Irvine, Calif). C, The Tiara Valve (Neovasc, Richmond, BC). D, The Twelve Valve (Medtronic Inc, Minneapolis, Minn).
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

3. The event horizon for transcatheter mitral therapy to enter clinical practice is upon us.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions